Klövern AB (publ)
Nykredit Bank A/S has through an agreement dated on 14 January 2021 acceded to Klövern AB (publ)’s unsecured MTN program (the ”MTN Program
”) as dealer in accordance with the general terms and conditions of the MTN Program originally dated on 4 February 2020 and as amended on 6 October 2020.
The other dealers under the MTN Program are Danske Bank A/S, Danmark, Sverige Filial, Nordea Bank Abp and Swedbank AB (publ).
Further information about the MTN Program can be found on Klövern’s website (www.klovern.se
).
Klövern AB (publ)
For additional information, please contact:
Jens Andersson, Head of Finance, +46 (0)76-855 67 02, jens.andersson@klovern.se
Rutger Arnhult, CEO, +46 (0)70-458 24 70, rutger.arnhult@klovern.se
Lars Norrby, IR, +46 (0)76-777 38 00, lars.norrby@klovern.se
Klövern is a real estate company committed to working closely with customers to offer them attractive premises in growth regions. Klövern is listed on Nasdaq Stockholm. For further information, see www.klovern.se.
Klövern AB (publ), Bredgränd 4, 111 30 Stockholm. Phone: +46 (0)10-482 70 00. E-mail: info@klovern.se
.
This is a translation of the original Swedish language press release. In the event of discrepancies, the original Swedish wording shall prevail.
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Spar Nord Bank A/S6.6.2025 10:31:01 CEST | Press release
Updated financial Calendar for 2025
Spar Nord Bank A/S6.6.2025 10:31:01 CEST | Pressemeddelelse
Opdateret finanskalender 2025
Vivoryon Therapeutics N.V.6.6.2025 09:45:00 CEST | Press release
Vivoryon Therapeutics N.V. Presents Meta-analysis Data of VIVIAD and VIVA-MIND studies at ERA 2025
OBI Pharma Inc.6.6.2025 09:00:00 CEST | Press release
OBI Pharma Enters ADC Collaboration with TegMine Therapeutics utilizing GlycOBI® and TegMiner™ Enabling Technologies
Tenneco6.6.2025 09:00:00 CEST | Press release
DRiV Introduces Walker® OE-Quality Starters, Alternators and Air Conditioning Parts – All Backed by 3-Year Warranty
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom